Skip to content

EBS

Emergent BioSolutions Inc.

NYSE · USHealthcareDrug Manufacturers - Specialty & Generic
$7.69+0.79%

Price as of Jul 20, 2026

EBS analysis

Emergent BioSolutions Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for EBS is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research